ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
2,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,Y
3,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
3,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
5,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
8,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
11,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
12,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
13,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
14,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
16,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
17,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
17,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
18,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
20,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
21,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
22,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
23,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
23,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
23,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
26,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
27,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
27,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
28,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
29,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
31,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
32,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
33,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
34,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
35,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
36,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
37,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
38,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
39,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
41,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
42,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
43,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
44,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
45,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
46,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
47,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
48,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
49,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
49,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
50,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
51,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
52,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
53,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
55,1,Ear malformation,Ear disorders congenital NEC,Ear and labyrinthine disorders congenital,Cong,N
55,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
55,3,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
56,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
58,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
58,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
59,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
59,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
60,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
61,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
62,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
63,1,Myxoedema,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
64,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
65,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
65,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
66,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
67,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
68,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
69,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
70,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
71,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
72,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
73,1,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
74,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
75,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
76,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
77,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
78,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,1,Retroperitoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,Y
80,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
81,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
82,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
83,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
83,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
84,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
85,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
86,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
87,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,Y
87,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
88,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
89,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
89,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
90,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
91,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
91,2,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
91,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
92,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
93,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
94,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
95,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
95,2,Squamous cell carcinoma of lung,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
96,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
97,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
97,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
98,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
98,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
98,3,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
99,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
100,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
100,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
101,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
102,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
102,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
102,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
103,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
103,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
103,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
104,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
106,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
106,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
107,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
107,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
108,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
108,2,Water intoxication,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
109,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
109,2,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
109,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
110,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
111,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
112,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
113,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
113,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
114,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
114,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
115,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
116,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,Y
117,1,Therapeutic response increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
118,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,Y
119,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
120,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
121,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
121,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
122,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
123,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
123,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
124,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
125,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,Y
126,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
127,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
128,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
129,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
129,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
129,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
130,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
131,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
132,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
133,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
133,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
134,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
136,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
137,1,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
138,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
139,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
141,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
141,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
141,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
142,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
143,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
144,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
144,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
145,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
146,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
147,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
148,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
149,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
150,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
150,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
150,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
151,1,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
151,2,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
152,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
153,1,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
154,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
154,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
155,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
156,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
157,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
157,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
158,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
159,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
160,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
161,1,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
162,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
163,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
164,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
164,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
165,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
166,1,Salivary gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
167,1,Congenital eye disorder,Ocular disorders congenital NEC,Eye disorders congenital,Cong,N
168,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
169,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
170,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
171,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
171,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
171,3,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
172,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
173,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
174,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
175,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
176,1,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
177,1,Headache,Headaches NEC,Headaches,Nerv,N
177,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
177,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
178,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
179,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
180,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
181,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
182,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
182,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
183,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
183,2,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,Y
183,3,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
184,1,Dupuytren's contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
185,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
186,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
186,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
187,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
188,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
189,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
190,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
191,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
192,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
193,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
193,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
194,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
195,1,Butterfly rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
196,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
196,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
196,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
197,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
197,2,Headache,Headaches NEC,Headaches,Nerv,N
197,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
197,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
197,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
198,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
198,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
198,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
199,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
199,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
199,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
200,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
200,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
200,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
201,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
202,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
202,2,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
203,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
204,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
205,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
205,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
205,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
206,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
207,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
208,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
209,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
210,1,Headache,Headaches NEC,Headaches,Nerv,N
210,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
210,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
210,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
211,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
212,1,Blood antidiuretic hormone increased,Pituitary analyses posterior,Endocrine investigations (incl sex hormones),Inv,N
212,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
213,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
214,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
215,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
216,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
217,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
217,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
217,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
218,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
219,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
219,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
219,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
220,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
221,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
221,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
222,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
223,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
223,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
224,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
225,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
225,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
225,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
225,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
225,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
226,1,Sideroblastic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
227,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
228,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
229,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
229,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
229,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
230,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
231,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
232,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
232,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
233,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
234,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
235,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
236,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
237,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
237,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
238,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
239,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
239,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
240,1,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
241,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
242,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
242,2,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
242,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
242,4,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
242,5,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
243,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
